11/14/2024
6:23 PM | Lind Global Fund II LP (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024
4:04 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form 424B3 | |
10/31/2024
3:30 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
5:15 AM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form ARS | |
10/24/2024
5:15 AM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form DEF 14A | |
10/11/2024
3:56 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form PRE 14A | |
09/30/2024
5:07 AM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
3:30 PM | Dunn Gordon (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
11:03 AM | Myers Michael (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
11:06 AM | Carter Denise P. (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:32 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form 424B3 | |
06/07/2024
11:24 AM | LANGER DENNIS (Reporting)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
11:15 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form EFFECT | |
04/02/2024
10:04 AM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form DEFA14A | |
03/29/2024
3:11 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form POS AM | |
03/14/2024
3:42 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
3:52 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:07 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form 424B4 | |
02/27/2024
5:01 AM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form DEF 14A | |
02/14/2024
11:15 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form EFFECT | |
02/13/2024
7:11 PM | Lind Global Fund II LP (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
4:12 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/18/2023
4:29 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
4:30 PM | Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
| Form 424B3 | |
